» Articles » PMID: 10462166

Anxiety of Alzheimer's Disease: Prevalence, and Comorbidity

Overview
Specialty Geriatrics
Date 1999 Aug 26
PMID 10462166
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Anxiety may be associated with psychiatric morbidity, disability, increased health care utilization, and mortality in Alzheimer's disease (AD) patients as it is in the general adult population. However, the phenomenology of anxiety symptoms in AD and its relationship to dementia progression, comorbid depression, and the presence of other problematic behaviors have not yet been examined.

Method: Data on anxiety symptoms and their coexistence with other factors were obtained in 523 community-dwelling AD patients through interviews with their caregivers and direct physical examination. The prevalence of anxiety symptoms and their association to patient depression, other behavioral problems, gender, and age was investigated.

Results: Anxiety symptoms were common, occurring in 70% of subjects. Anxiety symptoms were significantly correlated with ADL impairment and other behavioral disturbances, including wandering, sexual misconduct, hallucinations, verbal threats, and physical abuse. Comorbidity of anxiety-depression was also prevalent: 54% of the sample had both anxiety and depression symptoms. ADL impairment and problem behaviors were significantly associated with comorbidity; however, the latter association was explained entirely by the presence of anxiety.

Conclusion: Anxiety symptoms were common and significantly related to ADL and additional neuropsychiatric problems in this sample. These results indicate the need for additional research into the phenomenology of anxiety and comorbid anxiety-depression in AD and for the development and investigation of effective assessment and treatment of anxiety in AD clinical practice.

Citing Articles

The neural basis of neuropsychiatric symptoms in Alzheimer's disease.

Zhang N, Zhang S, Zhang L, Tao H, Zhang G Front Aging Neurosci. 2024; 16:1487875.

PMID: 39703925 PMC: 11655510. DOI: 10.3389/fnagi.2024.1487875.


Trait-anxiety and glial-related neuroinflammation of the amygdala and its associated regions in Alzheimer's disease: A significant correlation.

Yasuno F, Kimura Y, Ogata A, Ikenuma H, Abe J, Minami H Brain Behav Immun Health. 2024; 38:100795.

PMID: 38799793 PMC: 11126804. DOI: 10.1016/j.bbih.2024.100795.


Advances in Therapeutics to Alleviate Cognitive Decline and Neuropsychiatric Symptoms of Alzheimer's Disease.

Li J, Haj Ebrahimi A, Ali A Int J Mol Sci. 2024; 25(10).

PMID: 38791206 PMC: 11121252. DOI: 10.3390/ijms25105169.


Modeling and mobile home monitoring of behavioral and psychological symptoms of dementia (BPSD).

Yuan H, Yang T, Xie Q, Lledos G, Chou W, Yu W BMC Psychiatry. 2024; 24(1):197.

PMID: 38461285 PMC: 10924368. DOI: 10.1186/s12888-024-05579-5.


Myelin Pathology in Alzheimer's Disease: Potential Therapeutic Opportunities.

Huang Z, Jordan J, Zhang Q Aging Dis. 2023; 15(2):698-713.

PMID: 37548935 PMC: 10917545. DOI: 10.14336/AD.2023.0628.